NVO - Novo Nordisk A/S
| Previous Close | 47.26 |
| Open | 47.41 |
| Bid | 47.50 x 1100 |
| Ask | 47.51 x 2900 |
| Day's Range | 47.36 - 47.84 |
| 52 Week Range | 41.23 - 52.83 |
| Volume | 1,056,873 |
| Avg. Volume | 1,268,646 |
| Market Cap | 113.352B |
| Beta (3Y Monthly) | 0.78 |
| PE Ratio (TTM) | 19.31 |
| EPS (TTM) | 2.46 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.25 (2.55%) |
| Ex-Dividend Date | 2019-03-22 |
| 1y Target Est | 53.90 |
- Simply Wall St.•9 days ago
Do You Know What Novo Nordisk A/S's (CPH:NOVO B) P/E Ratio Means?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
- Zacks•12 days ago
Pharma Stock Roundup: AGN, NVO Report Q1 Earnings, NVS to Buy Takeda's Eye Drug
Allergan (AGN) and Novo Nordisk (NVO) announce Q1 results. Novartis buys rights to Takeda's dry eye disease drug, Xiidra.
- Motley Fool•12 days ago
Novo Nordisk Trots Along Waiting for Its Next-Generation Oral Drug
Oral semaglutide is on its way.
Motley Fool•18 days agoNovo Nordisk A/S (NVO) Q1 2019 Earnings Call Transcript
NVO earnings call for the period ending March 31, 2019.
- Zacks•19 days ago
Novo Nordisk (NVO) Q1 Earnings and Revenues Miss Estimates
Novo Nordisk's (NVO) earnings and sales miss estimates in the first quarter of 2019.
- Zacks•19 days ago
Gilead (GILD) Earnings Beat, Revenues Miss Estimates in Q1
Biotech bigwig Gilead's (GILD) Q1 financial report is mixed with dismal sales and an earnings beat.
- Benzinga•19 days ago
The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 2) Alcon AG (NYSE: ALC ) Dr.Reddy's Laboratories Ltd (NYSE: ...
- Zacks•20 days ago
What's in the Cards for AEterna (AEZS) This Earnings Season?
AEterna (AEZS) may provide update on the path forward for Macrilen in Europe on the first-quarter earnings call.
- Zacks•20 days ago
Why Earnings Season Could Be Great for Novo Nordisk (NVO)
Novo Nordisk (NVO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Motley Fool•20 days agoStrongbridge Biopharma (SBBP) Q1 2019 Earnings Call Transcript
SBBP earnings call for the period ending March 31, 2019.
Motley Fool•21 days agoStrongbridge Biopharma plc (SBBP) Q1 2019 Earnings Call Transcript
SBBP earnings call for the period ending March 31, 2019
- Zacks•21 days ago
Can Allergan (AGN) Beat Earnings Estimates Again in Q1?
Allergan's (AGN) key products like Botox are likely to provide top-line support in Q1 as loss of exclusivity of several products hurts sales
- PR Newswire•21 days ago
Renewable electricity to completely power Novo Nordisk US operations in early 2020
PLAINSBORO, N.J., April 30, 2019 /PRNewswire/ -- Beginning in early 2020, Novo Nordisk's global production will be completely powered by renewable electricity, with a ten-year goal of achieving zero carbon emissions from operations and transportation. The announcement follows a $70 million investment in a 105-megawatt dc solar energy installation to be built in Pender County, North Carolina. When completed, ground-mounted solar arrays will harvest sunlight and provide renewable electricity to all existing Novo Nordisk US offices, laboratories and manufacturing facilities as well as to support the new manufacturing facility under construction in Clayton, N.C. Developed and constructed by Cypress Creek Renewables, the solar panel installation will be one of North Carolina's largest solar sites.
- Zacks•22 days ago
What's in Store for ANI Pharmaceuticals (ANIP) Q1 Earnings?
ANI Pharmaceuticals (ANIP) will provide updates on product launches, when it releases first-quarter 2019 results.
- Zacks•22 days ago
What's in Store for BioSpecifics (BSTC) This Earnings Season?
BioSpecifics Technologies (BSTC) will provide updates on Xiaflex and pipeline progress, when it releases first-quarter 2019 results.
- Zacks•22 days ago
Arcus (RCUS) to Report Q1 Earnings: What's in the Cards?
Arcus (RCUS) is expected to provide an update on its pipeline with the release of its first-quarter 2019 results
- Motley Fool•25 days ago
2 Reasons Gilead Sciences' NASH Program Could Bounce Back
It's been a rough few years, but an unexpected partnership could put the biotech's liver disease program back on top.
- Zacks•25 days ago
Will HIV Franchise Sales Drive Gilead's (GILD) Q1 Earnings?
Investors are expected to focus on the HIV franchise and other pipeline updates, when Gilead (GILD) reports first-quarter results.
- Investopedia•26 days ago
The Top 10 Biotechnology Companies (JNJ, ROG.VX)
Learn how the marriage of science and technology is changing the world of medicine and creating some of the largest multinational biotechnology corporations.
- Zacks•27 days ago
Lannett (LCI) to Report Q3 Earnings: What's in the Cards?
Lannet (LCI) will release fiscal third-quarter earnings and is expected to provide an update on product launches
- Zacks•29 days ago
Alexion (ALXN) to Report Q1 Earnings: What's in the Cards?
Alexion's (ALXN) first-quarter 2019 results are likely to gain on solid performance of lead drug, Soliris. Investors will also focus on updates on pipeline candidates.
- Zacks•29 days ago
What's in Store for Bayer (BAYRY) This Earnings Season?
Bayer (BAYRY) is expected to provide pipeline updates along with its first-quarter results.
- Zacks•last month
Novo Nordisk's (NVO) Share Price Rises YTD on Strong Pipeline
Share price of Novo Nordisk (NVO) has increased year to date on strong presence in the Diabetes Care market and a solid pipeline.
- Zacks•last month
Gilead Collaborates With Insitro to Develop NASH Therapies
Gilead (GILD) collaborates with data-driven company, Insitro, to harness the power of computers to discover and develop therapies for treating NASH (fatty liver).
- Zacks•last month
Biotech Stock Roundup: GILD Collaborates on NASH, FCSC Surges on Deal
Key highlights of the past week are collaborations and pipeline updates.
